- £182.61bn
- £218.59bn
- $316.62bn
- 75
- 80
- 98
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 344,877 | 180,543 | 261,504 | 381,314 | 316,620 |
Cost of Revenue | |||||
Gross Profit | 65,456 | 39,449 | 62,770 | 97,308 | 78,497 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 320,130 | 206,284 | 233,676 | 319,196 | 286,345 |
Operating Profit | 24,747 | -25,741 | 27,828 | 62,118 | 30,275 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 25,485 | -26,967 | 29,829 | 64,815 | 32,627 |
Provision for Income Taxes | |||||
Net Income After Taxes | 16,432 | -21,534 | 20,630 | 42,874 | 19,636 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 15,842 | -21,680 | 20,101 | 42,309 | 19,359 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 15,842 | -21,680 | 20,101 | 42,309 | 19,359 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.99 | 1.96 | 2.49 | 5.2 | 3.98 |
Dividends per Share |